These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 23224486)

  • 21. [Use of aripiprazole in the treatment of catatonia].
    Vörös V; Tényi T
    Neuropsychopharmacol Hung; 2010 Jun; 12(2):373-6. PubMed ID: 20606247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effectiveness and safety of adjunctive aripiprazole in Taiwanese patients with antidepressant-refractory major depressive disorder: a prospective, open-label trial.
    Chen SJ; Hsiao YL; Shen TW; Chen ST
    J Clin Psychopharmacol; 2012 Feb; 32(1):56-60. PubMed ID: 22198444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aripiprazole augmentation for major depressive disorder: dosing patterns in a naturalistic treatment setting.
    Pae CU; Wang SM; Han C; Lee SJ; Patkar AA; Masand PS
    Int Clin Psychopharmacol; 2014 Mar; 29(2):116-9. PubMed ID: 24108149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of suicidality in pooled data from 2 double-blind, placebo-controlled aripiprazole adjunctive therapy trials in major depressive disorder.
    Weisler RH; Khan A; Trivedi MH; Yang H; Eudicone JM; Pikalov A; Tran QV; Berman RM; Carlson BX
    J Clin Psychiatry; 2011 Apr; 72(4):548-55. PubMed ID: 20816039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of aripiprazole in a child with involuntary emotional expression disorder.
    Magaudda A; Imbesi D; Di Rosa G
    J Neuropsychiatry Clin Neurosci; 2012; 24(2):E5-6. PubMed ID: 22772704
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial.
    Mischoulon D; Witte J; Levy M; Papakostas GI; Pet LR; Hsieh WH; Pencina MJ; Ward S; Pollack MH; Fava M
    J Clin Psychiatry; 2012 Mar; 73(3):353-7. PubMed ID: 21939613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of aripiprazole on the subscales of the Kellner Symptom Questionnaire in treatment resistant depression.
    Dording C; Cassiello C; King F; Pencina M; Fava M; Mischoulon D
    Int Clin Psychopharmacol; 2013 Sep; 28(5):238-44. PubMed ID: 23764521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.
    Thase ME; Jonas A; Khan A; Bowden CL; Wu X; McQuade RD; Carson WH; Marcus RN; Owen R
    J Clin Psychopharmacol; 2008 Feb; 28(1):13-20. PubMed ID: 18204335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aripiprazole: a clinical review of its use for the treatment of anxiety disorders and anxiety as a comorbidity in mental illness.
    Katzman MA
    J Affect Disord; 2011 Jan; 128 Suppl 1():S11-20. PubMed ID: 21220076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three cases of hypomania and one case of mania during aripiprazole treatment.
    Viikki M; Valtonen HM; Leinonen E
    Pharmacopsychiatry; 2011 Mar; 44(2):78-81. PubMed ID: 21157696
    [No Abstract]   [Full Text] [Related]  

  • 31. Aripiprazole-induced gray matter growth in a patient with major depressive disorder with panic disorder.
    Lai CH
    J Clin Psychiatry; 2010 Mar; 71(3):360-2. PubMed ID: 20331938
    [No Abstract]   [Full Text] [Related]  

  • 32. Effectiveness of aripiprazole, olanzapine, quetiapine, and risperidone augmentation treatment for major depressive disorder: a nationwide population-based study.
    Lin CY; Tsai GE; Wang HS; Wu YH; Chiou CC; Wu VY; Lane HY
    J Clin Psychiatry; 2014 Sep; 75(9):e924-31. PubMed ID: 25295435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comments on "Aripiprazole in major depression and mania: meta-analyses of randomized placebo-controlled trials".
    Pae CU
    Gen Hosp Psychiatry; 2010; 32(4):448; author reply 449. PubMed ID: 20633759
    [No Abstract]   [Full Text] [Related]  

  • 34. Dosing patterns of aripiprazole and quetiapine for adjunctive treatment of major depressive disorder (2006-2010).
    Jing Y; Guo Z; Kalsekar I; Forbes RA; Hebden T; Thase ME
    Int Clin Psychopharmacol; 2013 Mar; 28(2):87-90. PubMed ID: 23262644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central sleep apnea in a geriatric patient treated with aripiprazole.
    Kohen I; Sarcevic A
    Am J Ther; 2009; 16(2):197-8. PubMed ID: 19300045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.
    Yatham LN
    J Affect Disord; 2011 Jan; 128 Suppl 1():S21-8. PubMed ID: 21220077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the efficacy between paroxetine and sertraline augmented with aripiprazole in patients with refractory major depressive disorder.
    Yoshimura R; Kishi T; Hori H; Ikenouchi-Sugita A; Katsuki A; Umene-Nakano W; Iwata N; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):355-7. PubMed ID: 22813840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Covert dyskinesia associated with aripiprazole: a case report and review of the literature.
    Moseley CN; Simpson-Khanna HA; Catalano G; Catalano MC
    Clin Neuropharmacol; 2013; 36(4):128-30. PubMed ID: 23860346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjunctive aripiprazole for bupropion-resistant major depression.
    Sokolski KN
    Ann Pharmacother; 2008 Jul; 42(7):1124-9. PubMed ID: 18492784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective, open-label study of Aripiprazole mono- and adjunctive treatment in acute bipolar depression.
    Dunn RT; Stan VA; Chriki LS; Filkowski MM; Ghaemi SN
    J Affect Disord; 2008 Sep; 110(1-2):70-4. PubMed ID: 18272230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.